These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 27637015)

  • 1. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
    Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
    Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.
    González-Rodríguez A; Mayoral R; Agra N; Valdecantos MP; Pardo V; Miquilena-Colina ME; Vargas-Castrillón J; Lo Iacono O; Corazzari M; Fimia GM; Piacentini M; Muntané J; Boscá L; García-Monzón C; Martín-Sanz P; Valverde ÁM
    Cell Death Dis; 2014 Apr; 5(4):e1179. PubMed ID: 24743734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
    Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease.
    Tang M; Jiang Y; Jia H; Patpur BK; Yang B; Li J; Yang C
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):159-168. PubMed ID: 31852298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning.
    Suzuki A; Kakisaka K; Suzuki Y; Wang T; Takikawa Y
    World J Gastroenterol; 2016 Jul; 22(28):6509-19. PubMed ID: 27605885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
    Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
    Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity.
    Li S; Dou X; Ning H; Song Q; Wei W; Zhang X; Shen C; Li J; Sun C; Song Z
    Hepatology; 2017 Sep; 66(3):936-952. PubMed ID: 28437863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease].
    Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329
    [No Abstract]   [Full Text] [Related]  

  • 9. The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease.
    Wu H; Zhou M; Jin Q; Wang X; Xu Y; Li M; Chen S; Tang Q; Wang Q; Hu B; Wu H; Xiao M; Qu L; Zhang Q; Liu J
    Hepatol Int; 2024 Aug; 18(4):1144-1157. PubMed ID: 38184503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
    Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
    J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous metabolite, kynurenic acid, attenuates nonalcoholic fatty liver disease via AMPK/autophagy- and AMPK/ORP150-mediated signaling.
    Pyun DH; Kim TJ; Kim MJ; Hong SA; Abd El-Aty AM; Jeong JH; Jung TW
    J Cell Physiol; 2021 Jul; 236(7):4902-4912. PubMed ID: 33283879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic CD147 knockout modulates liver steatosis and up-regulates autophagy in high-fat-diet-induced NAFLD mice.
    Lou J; Li C; Li ZS; Zhang T; Chen ZN; Bian H
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1010-1017. PubMed ID: 32063360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.
    Liu X; Li X; Su S; Yuan Y; Liu W; Zhu M; Zheng Q; Zeng X; Fu F; Lu Y; Chen Y
    Exp Cell Res; 2023 Aug; 429(2):113655. PubMed ID: 37253404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
    Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
    Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-38 alleviates hepatic steatosis through AMPK/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models.
    Sun JL; Cho W; Oh H; Abd El-Aty AM; Hong SA; Jeong JH; Jung TW
    J Cell Physiol; 2024 Apr; 239(4):e31184. PubMed ID: 38197464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD.
    Ma D; Molusky MM; Song J; Hu CR; Fang F; Rui C; Mathew AV; Pennathur S; Liu F; Cheng JX; Guan JL; Lin JD
    Mol Endocrinol; 2013 Oct; 27(10):1643-54. PubMed ID: 23960084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
    Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
    Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
    Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
    Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.